Tuberc Respir Dis.  2003 Mar;54(3):295-303. 10.4046/trd.2003.54.3.295.

Prevalence and Clinical Outcome of Penicillin-resistant Pneumococcal Pneumonia

Affiliations
  • 1Division of Pulmonology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, College of Medicine, Hallym University, Anyang, Korea. pulmoks@hallym.or.kr
  • 2Department of Clinical Pathology, Hallym University Sacred Heart Hospital, College of Medicine, Hallym University, Anyang, Korea.

Abstract

BACKGROUND: The incidence of penicillin-resistant streptococcus pneumoniae(PRSP) accounts for almost 70% of all pneumococcal pneumonia cases in Korea. It is still unclear as to whether the efficacy of penicillin or equally active beta-lactam agents is compromised in PRSP pneumonia. This study investigated the prevalence of PRSP in community-acquired pneumonia and its clinical course.
METHODS
A total of 42 patients with community-acquired pneumococcal pneumonia were evaluated from July 1999 to May 2001. The cultured strains of Streptococcus pneumoniae were divided into susceptible, intermediately resistant, and resistant strains by an E-test, and the effect of the clinical course was investigated.
RESULTS
From a total of 42 patients, 22 (52.4%) patients had an intermediate resistance (MIC 0.1-1 microgram/ml) and six (14.3%) showed a high resistance (MIC> or =2.0 microgram/ml) with current penicillin susceptibility categories. However, according to the classification of the DRSPTWG (Drug Resistant Streptococcus pneumoniae Therapeutic Working Group), there were 11 cases (26.2%) of intermediate resistance and no case of high resistance. Under empirical antimicrobial treatment, there was no difference in the clinical outcome between the penicillin susceptible and resistant group.
CONCLUSION
The clinical outcome of PRSP pneumonia with empirical therapy was acceptable. These results suggest that the current MIC breakpoint for penicillin resistance in Streptococcus pneumoniae has been set at a very low level and penicillin resistance according to the NCCLS classification does not significantly influence the outcome of the empirical treatment for pneumococcal pneumonia.

Keyword

Penicillin-resistance; Streptococcus pneumoniae; Pneumonia; Prognosis

MeSH Terms

Classification
Humans
Incidence
Korea
Penicillin Resistance
Penicillins
Pneumonia
Pneumonia, Pneumococcal*
Prevalence*
Prognosis
Streptococcus
Streptococcus pneumoniae
Penicillins

Cited by  3 articles

A 2011-2012 Survey of Doctors' Perceptions of Korean Guidelines and Empirical Treatment of Community-Acquired Pneumonia
Hye-In Kim, Shin-Woo Kim, Hyun-Ha Chang, Jong-Myung Lee, Kyong Ran Peck
Infect Chemother. 2013;45(4):394-405.    doi: 10.3947/ic.2013.45.4.394.

Treatment Guidelines for Community-acquired Pneumonia in Korea: An Evidence-based Approach to Appropriate Antimicrobial Therapy
Jae-Hoon Song, Ki-Suck Jung
J Korean Med Assoc. 2010;53(1):20-42.    doi: 10.5124/jkma.2010.53.1.20.

Treatment Guidelines for Community-acquired Pneumonia in Korea: An Evidence-based Approach to Appropriate Antimicrobial Therapy
Jae-Hoon Song, Ki-Suck Jung, Moon Won Kang, Do Jin Kim, Hyunjoo Pai, Gee Young Suh, Tae Sun Shim, Joong Hyun Ahn, Chul Min Ahn, Jun Hee Woo, Nam Yong Lee, Dong-Gun Lee, Mi Suk Lee, Sang Moo Lee, Yeong Seon Lee, Hyukmin Lee, Doo Ryeon Chung
Infect Chemother. 2009;41(3):133-153.    doi: 10.3947/ic.2009.41.3.133.

Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr